Article Hero

Markets rejoice over a potential COVID-19 vaccine - Monday Review, August 24

1598342183.jpg
Miguel A. Rodriguez
Miguel A. Rodriguez
14 September 2020
All seems to be good between the US and China

The US

The announcement of a possible vaccine for #COVID-19 moved the benchmarks higher. On top of that, China reaffirmed its commitment to Phase 1 of the trade deal. USA30 rose 1.36%, while USA500 added 1.05%. TECH100 went up 0.60%. 

Oil gained 0.9% and settled at $42.73 per barrel, while Brent Oil was up 1.3% to $45.50.

Gold settled down 0.4% at $1,939.20 per ounce. 

The Dollar Index traded at 93.30. 


Asia and Australia

HongKong45 jumped 1.64% after the recent call between the country’s representatives and the US counterparts regarding the deal signed at the beginning of this year.

Japan225 added 0.26% as Prime Minister Abe Shinzo paid a second visit to a hospital in Tokyo, raising concerns about his health. 

Down under, Australia200 inched up 0.04%, as the state of Victoria reported 116 new cases of COVID-19 infection on Monday, raising hopes that the recent #outbreak is subsiding. 

USD/JPY traded at 105.97.


Europe

The stocks moved higher boosted by the prospects of a COVID-19 #vaccine available by November.

Germany30 and UK100 traded 1.4% higher. France40 rose 1.8%. 

EUR/USD went up 0.1% to 1.1810.

GBP/USD traded at 1.3068. 

Read all about the potential vaccine here!

Sources: reuters.com, investing.com

The information presented herein is prepared by CAPEX.com/eu and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.                                                                                                                            Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience, or current financial situation.Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance and forecasts are not reliable indicators of future results.

Share this article

How did you find this article?

Awful
Ok
Great
Awesome

Read More

Miguel A. Rodriguez
Miguel A. Rodriguez
Financial Writer

Miguel worked for major financial institutions such as Banco Santander, and Banco Central-Hispano. He is a published author of currency trading books. 

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69.69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.